Type 2 Diabetes
To assess whether treatment with permafibrate will prevent myocardial infarction, ischemic stroke, unstable angina, and cardiovascular death in adults with Type 2 Diabetes Mellitus.
Principal Investigator: Marcus McKenzie, MD
Locations: Legacy Heart Center Plano
Sponsor: Kowa Research Institute
IRB Number: 017-488
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating will change your care
Alexandria Biberstein, RN469.814.4732Alexandria.Biberstein@BSWHealth.org
Permafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes.
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.